case_images: PMC6324144_01
case_images: A baseline photograph shows superficial and deep corneal neovascularization affecting the visual axis
case_images: IJO-67-145-g001.jpg
case_images: PMC6324144_01_IJO-67-145-g001.jpg
case_images: F1
case_images: Fig. 1 shows the anterior segment image of the patient before topical aflibercept treatment.
case_images: Complete resolution of corneal neovascularization is observed 7 days after initiating topical aflibercept
case_images: IJO-67-145-g002.jpg
case_images: PMC6324144_01_IJO-67-145-g002.jpg
case_images: F2
case_images: Significant regression of the neovascularization was observed 3 days after starting treatment and nearly all of the vessels disappeared within 1 week [Fig. 2].
case_images: At 1-year follow-up, the only apparent finding is superficial leucoma in central cornea
case_images: IJO-67-145-g003.jpg
case_images: PMC6324144_01_IJO-67-145-g003.jpg
case_images: F3
case_images: Superficial leucoma was noted in the central cornea [Fig. 3].